|
1
|
Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.
|
Int J Radiat Oncol Biol Phys
|
2009
|
2.33
|
|
2
|
Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence.
|
BMC Cancer
|
2012
|
1.92
|
|
3
|
A comparison between the Chinese 2008 and the 7th edition AJCC staging systems for nasopharyngeal carcinoma.
|
Am J Clin Oncol
|
2015
|
1.42
|
|
4
|
Anterior versus posterior routes of reconstruction after esophagectomy: a comparative anatomic study.
|
Ann Thorac Surg
|
2009
|
1.40
|
|
5
|
Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma.
|
Int J Radiat Oncol Biol Phys
|
2011
|
1.33
|
|
6
|
Efficacy of sorafenib on metastatic renal cell carcinoma in Asian patients: results from a multicenter study.
|
BMC Cancer
|
2009
|
1.22
|
|
7
|
The role of palliative radiation therapy in symptomatic locally advanced gastric cancer.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.18
|
|
8
|
The role of local therapy in the management of lung and liver oligometastases.
|
Nat Rev Clin Oncol
|
2011
|
1.17
|
|
9
|
Radiation-induced cranial nerve palsy: a cross-sectional study of nasopharyngeal cancer patients after definitive radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.14
|
|
10
|
Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer.
|
Am J Clin Oncol
|
2010
|
1.12
|
|
11
|
A study of complications arising from different methods of anesthesia used in high-dose-rate brachytherapy for cervical cancer.
|
Am J Clin Oncol
|
2004
|
1.04
|
|
12
|
Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
|
Cancer J
|
2008
|
0.99
|
|
13
|
Can all centers plan intensity-modulated radiotherapy (IMRT) effectively? An external audit of dosimetric comparisons between three-dimensional conformal radiotherapy and IMRT for adjuvant chemoradiation for gastric cancer.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.99
|
|
14
|
Evaluation of an audit with feedback continuing medical education program for radiation oncologists.
|
J Cancer Educ
|
2005
|
0.98
|
|
15
|
Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity.
|
Leuk Lymphoma
|
2007
|
0.97
|
|
16
|
Combined high-dose radiation therapy and systemic chemotherapy improves survival in patients with newly diagnosed metastatic nasopharyngeal cancer.
|
Am J Clin Oncol
|
2012
|
0.96
|
|
17
|
Patient preference for radiotherapy fractionation schedule in the palliation of painful bone metastases.
|
J Clin Oncol
|
2003
|
0.92
|
|
18
|
Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.90
|
|
19
|
The clinical significance of coexpression of cyclooxygenases-2, vascular endothelial growth factors, and epidermal growth factor receptor in nasopharyngeal carcinoma.
|
Laryngoscope
|
2008
|
0.89
|
|
20
|
Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
|
Oral Oncol
|
2007
|
0.89
|
|
21
|
Cultural attitudes to cancer management in traditional South-East Asian patients.
|
Australas Radiol
|
2002
|
0.88
|
|
22
|
Emerging application of stereotactic body radiation therapy for gynecologic malignancies.
|
Expert Rev Anticancer Ther
|
2011
|
0.87
|
|
23
|
Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
|
Cancer J
|
2008
|
0.87
|
|
24
|
Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma.
|
Head Neck
|
2012
|
0.87
|
|
25
|
Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases.
|
Cochrane Database Syst Rev
|
2014
|
0.85
|
|
26
|
Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence.
|
Radiat Oncol
|
2010
|
0.84
|
|
27
|
Stereotactic body radiation therapy for oligometastases.
|
Discov Med
|
2010
|
0.83
|
|
28
|
Adjuvant chemoradiotherapy with or without intraoperative radiotherapy for the treatment of resectable locally advanced gastric adenocarcinoma.
|
Radiother Oncol
|
2011
|
0.82
|
|
29
|
Emerging applications of stereotactic body radiation therapy for head and neck cancer.
|
Expert Rev Anticancer Ther
|
2011
|
0.80
|
|
30
|
Stereotactic body radiation therapy (SBRT) for genitourinary malignancies.
|
Discov Med
|
2010
|
0.80
|
|
31
|
Application of a modified McKeown procedure (thoracoscopic esophageal mobilization three-incision esophagectomy) in esophageal cancer surgery: initial experience with 30 cases.
|
Dis Esophagus
|
2009
|
0.80
|
|
32
|
Addition of intracavitary brachytherapy to external beam radiation therapy for T1-T2 nasopharyngeal carcinoma.
|
Brachytherapy
|
2013
|
0.79
|
|
33
|
Adjuvant chemoradiation plus intraoperative radiotherapy versus adjuvant chemoradiation alone in patients with locally advanced rectal cancer.
|
Am J Clin Oncol
|
2015
|
0.76
|
|
34
|
External audit of clinical practice and medical decision making in a new Asian oncology center: results and implications for both developing and developed nations.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.76
|
|
35
|
Intraoperative radiotherapy in the combination of adjuvant chemotherapy for the treatment of pT3N0M0 rectal cancer after radical surgery.
|
Am J Clin Oncol
|
2014
|
0.75
|
|
36
|
Adjuvant intraoperative electron radiotherapy and external beam radiotherapy for locally advanced transitional cell carcinoma of the ureter.
|
Urol Oncol
|
2008
|
0.75
|
|
37
|
Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
|
Laryngoscope
|
2006
|
0.75
|
|
38
|
A comparison of RANZCR and Singapore-designed radiation oncology practice audit instruments: how does reproducibility affect future approaches to revalidation?
|
Australas Radiol
|
2004
|
0.75
|